• Investment World
• eWorld
• Catalyst
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Port Info

• Ships in Ports
  
  

Archives

• Yesterday
• Datewise
• Resources

Group Sites

• The Hindu
• Business Line
• The Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Hyderabad , Jan. 29

KREBS Biochemicals & Industries Ltd (KBIL), the active pharmaceutical ingredients and sugar manufacturer, has suffered a fall both in turnover and net profit for the third quarter of current fiscal ended December 2004.

As per the unaudited financial results taken on record here on Saturday, the company achieved a turnover of Rs 20.77 crore against Rs 23.21 crore in the corresponding quarter of previous fiscal and posted a lower net profit of Rs 2.42 crore (Rs 5.04 crore), yielding earnings per share (EPS) of Rs 4.04 (Rs 8.42) on an equity base of Rs 6 crore.

For the nine-month period, the company posted a net profit of Rs 11.34 crore (Rs 15.57 crore) on a turnover of Rs 70.8 crore (Rs 84.6 crore).

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
MTNL Q3 net down at Rs 200.9 crore

Copyright © 2005, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line